虚拟筛选和先导化合物优化以鉴定HDAC-8的新型抑制剂
Virtual screening and lead optimisation to identify novel inhibitors for HDAC-8
摘要:
组蛋白脱乙酰酶(HDAC)和组蛋白乙酰转移酶(HAT)是通过选择性地使位于核心组蛋白的氨基末端附近的赖氨酸的(N)-氨基脱乙酰化或乙酰化来影响转录的酶。HDAC的过度表达在包括白血病和乳腺癌在内的许多形式的癌症中观察到。HDAC抑制剂已被证明是生长停滞、分化和/或凋亡性细胞死亡的有效诱导剂。组蛋白去乙酰化酶抑制剂作为抗癌药物的研究越来越受到人们的关注。取HDAC-8的三个已知配体并对接。最好的分数被分析,与这些配体相似的结构被用carol和corina数据库下载并对接。还使用分子对接计算筛选小分子的大数据库,以获得可以在构象和化学上适合活性位点的命中。选择GoldScore和ChemScore得分高的分子,并与以前的结果进行比较。最佳结果被用来计算氢键相互作用和紧密接触。进行了最佳排序配体的生物活性预测。并对其理化性质进行了分析。四个新的分子被确定,并建议在湿实验室进一步测试。
英文摘要:
Histone deacetylase (HDAC) and Histone acetyl-transferase (HAT) are enzymes that influence transcription by selectively deacetylating or acetylating the (epsilon)-amino groups of lysine located near the amino termini of core histone proteins. Over expression of HDACs noted in many forms of cancers including leukemia and breast cancer. HDAC inhibitors have been shown to be potent inducers of growth arrest, differentiation, and/or apoptotic cell death. There is a growing interest in the development of histone deacetylase inhibitors as anti cancer agents. Three known ligands of HDAC-8 were taken and docked. The best scores were analyzed and structures similar to these ligands were downloaded using carol and corina databases and docked. Also large databases of small molecules were computationally screened using molecular docking for hits that can conformationally and chemically fit to the active site. Molecules which got high scores for both GoldScore and ChemScore were selected and compared with the previous results. Those with best results were then taken for calculating H-bond interactions and close contacts. Bioactivity prediction of the best ranked ligands was done. Their physicochemical properties were also analyzed. Four new molecules were identified and suggested for further testing in the wet lab.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。